journal article·2021-11-17

Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy

Yuhua Cao, Shuaishuai Ding, Lijuan Zeng, Jingya Miao, Kai Wang, Gang Chen, Chunyan Li, Jingrong Zhou, Xiu-wu Bian, Gan Tian

ACS Applied Materials & Interfaces· Volume 13· Issue 45
Publisher page

Abstract

With the recent success of immune checkpoint blockade (ICB) in cancer immunotherapy, there has been renewed interest in evaluating the combination of ICB inhibitors with radiotherapy (RT) in clinical trials in view of the localized RT-initiated vaccination effect, which can be augmented further by systemic immune-stimulating agents. Unfortunately, traditional RT/ICB accompanies severe toxicity from high-dose ionizing irradiation and low response rate from RT-aggravated immunosuppression, among which M2-type tumor-associated macrophages (TAMs) play an important role. Herein, CpG-decorated gold (Au) nanoparticles (CpG@Au NPs) were fabricated to improve the RT/ICB efficacy by immune modulation under low-dose X-ray exposure, where Au NPs served as radioenhancers to minimize the radiotoxicity, and yet acted as nanocarriers to deliver CpG, a toll-like receptor 9 agonist, to re-educate immunosuppressive M2 TAMs to immunostimulatory M1 counterparts, thus arousing innate immunity and meanwhile priming T cell activation. When combined with an anti-programmed death 1 antibody, irradiated CpG@Au led to consistent abscopal responses that efficiently suppressed distant tumors in a bilateral GL261 tumor-bearing model. This work thus demonstrates that CpG@Au-mediated macrophage reeducation could efficiently modulate the tumor-immune microenvironment for synergistic RT/ICB.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Pathology and Southwest Cancer Center, The First Affiliated Hospital, Third Military Medical University (Army Medical University), and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, P. R. China

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai 200032, P. R. China

Funding

Ministry of Science and Technology of the People's Republic of China · Army Medical University · Natural Science Foundation of Chongqing · National Natural Science Foundation of China · Southwest Hospital

References (48)

Show source-provided references
1. 10.1038/s41578-019-0108-110.1038/s41578-019-0108-1 ↗
2. 10.1002/adhm.20180042410.1002/adhm.201800424 ↗
3. 10.1038/s41577-019-0218-410.1038/s41577-019-0218-4 ↗
4. 10.1016/j.immuni.2018.03.00710.1016/j.immuni.2018.03.007 ↗
5. 10.1016/j.ccell.2015.03.01510.1016/j.ccell.2015.03.015 ↗
6. 10.1038/nrclinonc.2016.21110.1038/nrclinonc.2016.211 ↗
7. 10.1038/s41571-019-0238-910.1038/s41571-019-0238-9 ↗
8. 10.1002/adma.20180222810.1002/adma.201802228 ↗
9. 10.1038/s41467-018-04703-w10.1038/s41467-018-04703-w ↗
10. 10.1002/adfm.20180254010.1002/adfm.201802540 ↗
11. 10.1021/jacs.0c0503910.1021/jacs.0c05039 ↗
12. 10.1038/s41572-019-0064-510.1038/s41572-019-0064-5 ↗
13. 10.1038/s41568-020-0246-110.1038/s41568-020-0246-1 ↗
14. 10.1126/scitranslmed.aal022510.1126/scitranslmed.aal0225 ↗
15. 10.1038/s41577-019-0127-610.1038/s41577-019-0127-6 ↗
16. 10.1002/adtp.20190018110.1002/adtp.201900181 ↗
17. 10.1016/j.ccell.2015.02.01510.1016/j.ccell.2015.02.015 ↗
18. 10.1038/s41551-018-0236-810.1038/s41551-018-0236-8 ↗
19. 10.1038/s41467-018-03225-910.1038/s41467-018-03225-9 ↗
20. 10.1038/s41467-019-11911-510.1038/s41467-019-11911-5 ↗
21. 10.1038/s41590-018-0292-y10.1038/s41590-018-0292-y ↗
22. 10.1038/nrd.2018.16910.1038/nrd.2018.169 ↗
23. 10.1002/adma.20190200710.1002/adma.201902007 ↗
24. 10.1126/science.125251010.1126/science.1252510 ↗
25. 10.1002/adma.20190436410.1002/adma.201904364 ↗
26. 10.1158/2159-8290.CD-18-028010.1158/2159-8290.CD-18-0280 ↗
27. 10.1158/2159-8290.CD-18-074310.1158/2159-8290.CD-18-0743 ↗
28. 10.1021/acsami.8b0663310.1021/acsami.8b06633 ↗
29. 10.1002/adfm.20190874310.1002/adfm.201908743 ↗
30. 10.1002/anie.20191142910.1002/anie.201911429 ↗
31. 10.1021/jacs.9b1104610.1021/jacs.9b11046 ↗
32. 10.1021/acsami.8b2036410.1021/acsami.8b20364 ↗
33. 10.1016/j.jconrel.2019.09.01110.1016/j.jconrel.2019.09.011 ↗
34. 10.1021/acsami.9b2107510.1021/acsami.9b21075 ↗
35. 10.1038/physci241020a010.1038/physci241020a0 ↗
36. 10.1007/s40843-018-9238-610.1007/s40843-018-9238-6 ↗
37. 10.1021/nl902830x10.1021/nl902830x ↗
38. 10.1039/C9NR09402D10.1039/C9NR09402D ↗
39. 10.1002/jcb.2764610.1002/jcb.27646 ↗
40. 10.1016/j.jconrel.2017.09.04310.1016/j.jconrel.2017.09.043 ↗
41. 10.1158/1078-0432.CCR-18-301610.1158/1078-0432.CCR-18-3016 ↗
42. 10.1073/pnas.172094811510.1073/pnas.1720948115 ↗
43. 10.1002/advs.20180201210.1002/advs.201802012 ↗
44. 10.1021/acsnano.9b0896210.1021/acsnano.9b08962 ↗
45. 10.1021/acsnano.9b0197910.1021/acsnano.9b01979 ↗
46. 10.1021/acs.nanolett.8b0356810.1021/acs.nanolett.8b03568 ↗
47. 10.1038/s41388-019-1072-310.1038/s41388-019-1072-3 ↗
48. 10.1002/adma.20200205410.1002/adma.202002054 ↗